Graybug Vision Inc (GRAY): Price and Financial Metrics
GRAY Price/Volume Stats
| Current price | $5.50 | 52-week high | $22.12 |
| Prev. close | $6.17 | 52-week low | $5.00 |
| Day low | $5.00 | Volume | 24,600 |
| Day high | $6.08 | Avg. volume | 2,165 |
| 50-day MA | $8.79 | Dividend yield | N/A |
| 200-day MA | $11.66 | Market Cap | 8.64M |
GRAY Stock Price Chart Interactive Chart >
Graybug Vision Inc (GRAY) Company Bio
GrayBug is a pharmaceutical company that focuses on developing the next generation of products for the treatment of chronic vision-threatening diseases of the retina and optic nerve. The company is currently developing a continuum of proprietary micro – and nanoparticle controlled release technologies and implants for strategic partnership and its own therapeutic products for major ocular disease indications including wet AMD and Glaucoma. The company was founded in 2011 and headquartered in Baltimore, Maryland.
GRAY Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -86.59% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -72.68% |
| 2021 | -93.69% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...